NEW: We've expanded Stock Detail, Screener, and Maps with new data

Stock Detail, Screener:
3, 5, 10-Year Performance
EV/EBITDA, EV/Sales
Dividend Growth (1, 3, 5 Years)
EPS & Sales Growth (3 Years)

Maps:
All from Screener plus:
ROA, ROE, ROIC
Quick & Current Ratios
LT Debt and Debt to Equity Ratios
Gross, Operating, and Net Margins

TMDX

Transmedics Group Inc

Jul 02 • 04:00PM ET

127.69

Dollar change -2.41
Percentage change -1.85	%

Healthcare • Medical Devices • USA • NASD

Peers: ABT EW MDT ISRG SYK TMO BSX ZBH IDXX NVCR

| Held by: IJR VTI IWM VB VXF VBK IJT IWO SPSM IHI

Scroll to Statements

Index	RUT	P/E	93.85	EPS (ttm)	1.36	Insider Own	3.71%	Shs Outstand	33.83M	Perf Week	-0.69%
Market Cap	4.32B	Forward P/E	50.33	EPS next Y	2.54	Insider Trans	-1.25%	Shs Float	32.58M	Perf Month	3.03%
Enterprise Value	4.53B	PEG	1.97	EPS next Q	0.45	Inst Own	117.53%	Short Float	24.13%	Perf Quarter	87.04%
Income	48.95M	P/S	8.85	EPS this Y	81.95%	Inst Trans	7.24%	Short Ratio	7.34	Perf Half Y	109.26%
Sales	488.23M	P/B	16.22	EPS next Y	38.07%	ROA	6.27%	Short Interest	7.86M	Perf YTD	104.80%
Book/sh	7.87	P/C	13.93	EPS next 5Y	47.55%	ROE	22.99%	52W High	177.37 -28.01%	Perf Year	-15.22%
Cash/sh	9.17	P/FCF	-	EPS past 3/5Y	- -	ROIC	6.26%	52W Low	55.00 132.16%	Perf 3Y	297.17%
Dividend Est.	-	EV/EBITDA	61.11	Sales past 3/5Y	144.36% 79.64%	Gross Margin	59.41%	Volatility	3.73% 4.42%	Perf 5Y	653.78%
Dividend TTM	-	EV/Sales	9.28	EPS Y/Y TTM	564.38%	Oper. Margin	10.76%	ATR (14)	5.66	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	8.32	Sales Y/Y TTM	64.43%	Profit Margin	10.03%	RSI (14)	49.14	Recom	1.70
Dividend Gr. 3/5Y	- -	Current Ratio	9.10	EPS Q/Q	99.66%	SMA20	-4.75%	Beta	2.11	Target Price	133.88
Payout	0.00%	Debt/Eq	1.95	Sales Q/Q	48.21%	SMA50	6.75%	Rel Volume	0.67	Prev Close	130.10
Employees	728	LT Debt/Eq	1.94	Earnings	May 08 AMC	SMA200	34.27%	Avg Volume	1.07M	Price	127.69
IPO	May 02, 2019	Option/Short	Yes / Yes	EPS/Sales Surpr.	165.25% 16.05%	Trades		Volume	713,470	Change	-1.85%

Date	Action	Analyst	Rating Change	Price Target Change
Dec-17-24	Downgrade	JP Morgan	Overweight → Neutral	$116 → $75
Nov-22-24	Downgrade	Needham	Buy → Hold
Oct-29-24	Reiterated	Oppenheimer	Outperform	$200 → $125
Oct-29-24	Reiterated	Needham	Buy	$208 → $109
Sep-24-24	Initiated	Robert W. Baird	Outperform	$200
Aug-21-24	Initiated	Needham	Buy	$208
Jun-06-24	Initiated	Cantor Fitzgerald	Overweight	$161
Jun-04-24	Initiated	Stephens	Overweight	$151
Mar-28-24	Initiated	Piper Sandler	Overweight	$95
Jul-19-23	Initiated	Robert W. Baird	Outperform
Aug-02-22	Upgrade	JP Morgan	Neutral → Overweight	$48
Oct-08-20	Downgrade	JP Morgan	Overweight → Neutral	$15
Apr-07-20	Initiated	Oppenheimer	Outperform	$25
May-28-19	Initiated	Morgan Stanley	Equal-Weight
May-28-19	Initiated	JP Morgan	Overweight
May-28-19	Initiated	Cowen	Outperform
May-28-19	Initiated	Canaccord Genuity	Buy

Show Previous Ratings

Jun-30-25 04:21AM	2 Stocks That Have Doubled This Year and Are Still Worth Buying (Motley Fool)
Jun-28-25 09:10AM	10 Under-the-Radar Healthcare Stocks With Incredible Growth Potential (Motley Fool)
Jun-26-25 08:23AM	Reasons to Retain TransMedics Stock in Your Portfolio for Now (Zacks)
Jun-24-25 03:09PM	Oppenheimer Raises TransMedics (TMDX) PT to $150 Following Key OrganOx Metra Label Update (Insider Monkey)
Jun-12-25 07:53AM	Mid-Cap Marvels: 3 Stocks That Crushed Sales Estimates in May (MarketBeat)
09:36AM	Loading…
Jun-09-25 09:36AM	TransMedics Group, Inc. (TMDX): A Bull Case Theory (Insider Monkey)
07:29AM	3 Medical Technology Stocks Outperforming in 2025 (MarketBeat)
Jun-05-25 10:02AM	3 High-Growth Stocks Traders Love and Investors Should Watch (MarketBeat)
Jun-02-25 09:55AM	TransMedics (TMDX) Just Flashed Golden Cross Signal: Do You Buy? (Zacks)
May-27-25 04:05PM	TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) (PR Newswire)
May-23-25 10:36AM	Reasons to Retain TransMedics Stock in Your Portfolio for Now (Zacks)
May-20-25 04:05PM	TransMedics to Present at Upcoming June Investor Conferences (PR Newswire)
May-15-25 12:20PM	Earnings Estimates Moving Higher for TransMedics (TMDX): Time to Buy? (Zacks)
12:00PM	What Makes TransMedics (TMDX) a New Buy Stock (Zacks)
May-14-25 04:51AM	2 Brilliant Stocks to Buy With $200 and Hold for 5 Years (Motley Fool)
11:13AM	Loading…
May-13-25 11:13AM	Is TransMedics Group, Inc. (TMDX) the Unstoppable Growth Stock to Invest in Now? (Insider Monkey)
05:18AM	TransMedics Group Stock Is Up 81% in 2025. Can It Climb Even Higher? (Motley Fool)
03:11AM	Why TransMedics Group (TMDX) Is Among the Best Performing Healthcare Stocks to Buy Now (Insider Monkey)
May-10-25 01:20PM	TransMedics Group, Inc. (TMDX): A Bull Case Theory (Insider Monkey)
May-09-25 04:03PM	TransMedics surges, Rocket Lab USA drops, Toast guidance beat (Yahoo Finance Video) +19.64% +6.48%
12:42PM	Why TransMedics Stock Is Skyrocketing Today (Motley Fool)
12:03PM	TMDX Stock Gains Post Q1 Earnings & Revenue Beat, Gross Margin Down (Zacks)
10:06AM	Former Highflier TransMedics Catapults To Seven-Month High On Liver-Driven Beat (Investor's Business Daily)
03:41AM	TransMedics Group Inc (TMDX) Q1 2025 Earnings Call Highlights: Record Revenue and Strategic ... (GuruFocus.com)
May-08-25 07:00PM	Compared to Estimates, TransMedics (TMDX) Q1 Earnings: A Look at Key Metrics (Zacks)
05:50PM	TransMedics (TMDX) Tops Q1 Earnings and Revenue Estimates (Zacks)
04:49PM	TransMedics: Q1 Earnings Snapshot (Associated Press Finance)
04:05PM	TransMedics Reports First Quarter 2025 Financial Results (PR Newswire)
May-07-25 05:20PM	TransMedics Group Q1 2025 Earnings Preview (Seeking Alpha)
09:55AM	TransMedics Group Inc (TMDX) Q1 2025: Everything You Need To Know Ahead Of Earnings (GuruFocus.com)
12:50PM	Loading…
May-06-25 12:50PM	3 Mid-Cap Medical Stocks Outperforming the Market (MarketBeat)
May-05-25 09:15AM	Insights Into TransMedics (TMDX) Q1: Wall Street Projections for Key Metrics (Zacks)
Apr-28-25 09:50AM	Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick (Zacks)
Apr-26-25 06:45AM	What Moved Markets This Week (Seeking Alpha)
Apr-25-25 09:45AM	Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick (Zacks)
Apr-24-25 04:05PM	TransMedics to Report First Quarter 2025 Financial Results on May 8, 2025 (PR Newswire)
07:45AM	1 Beaten-Down Stock to Buy Right Now and Hold for a Decade (Motley Fool)
Apr-23-25 04:23AM	TransMedics: Get Some Exposure Despite Market Concerns (Seeking Alpha)
Apr-22-25 06:53AM	TransMedics: Downgrading To Sell As Growth Hurdles Mount (Seeking Alpha)
Apr-14-25 08:38AM	TransMedics Group (TMDX) Financial Success Faces Legal Scrutiny Amid Allegations Hagens Berman (GlobeNewswire) +7.77%
08:04AM	Scott+Scott Attorneys at Law LLP Reminds Investors of the Ongoing Action Against TransMedics Group, Inc. (TMDX) (Newsfile)
Apr-12-25 08:01AM	Scott+Scott Attorneys at Law LLP Reminds Investors a Securities Action Has Been Filed Against TransMedics Group, Inc. (TMDX) (Newsfile)
Apr-11-25 05:45AM	TransMedics Group, Inc. Sued for Securities Law Violations - Contact Levi & Korsinsky Before April 15, 2025 to Discuss Your Rights - TMDX (PR Newswire) +5.51%
Apr-10-25 09:21AM	TransMedics Group (TMDX) Financial Success Faces Legal Scrutiny Amid Allegations Hagens Berman (GlobeNewswire)
Apr-08-25 01:19PM	TransMedics Group (TMDX) Financial Success Faces Legal Scrutiny Amid Allegations Hagens Berman (GlobeNewswire)
09:20AM	TransMedics Group, Inc. (TMDX): A Bull Case Theory (Insider Monkey)
05:45AM	Investors in TransMedics Group, Inc. Should Contact Levi & Korsinsky Before April 15, 2025 to Discuss Your Rights - TMDX (PR Newswire)
Apr-06-25 03:29PM	TransMedics Group (TMDX) Financial Success Faces Legal Scrutiny Amid Allegations Hagens Berman (GlobeNewswire)
Apr-04-25 02:30PM	Stock Picks From Seeking Alpha's March 2025 New Analysts (Seeking Alpha)
01:43PM	Shareholders of TransMedics Group, Inc. Should Contact Levi & Korsinsky Before April 15, 2025 to Discuss Your Rights TMDX (GlobeNewswire)
10:42AM	TransMedics Group (TMDX) Financial Success Faces Legal Scrutiny Amid Allegations Hagens Berman (GlobeNewswire)
05:45AM	TransMedics Group, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky Before April 15, 2025 to Discuss Your Rights - TMDX (PR Newswire)
Apr-03-25 09:45AM	TransMedics Group (TMDX) Financial Success Faces Legal Scrutiny Amid Allegations - Hagens Berman (Newsfile)
Apr-02-25 04:05PM	TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) (PR Newswire) +7.09%
09:30AM	TransMedics Group (TMDX) Shares Down 60% From Class Period High, Class-Action Suit Pending Hagens Berman (GlobeNewswire)
08:10AM	Is Transmedics' (TMDX) Long-Term Growth Potential Still Intact? (Insider Monkey)
12:01AM	Lord Abbett Developing Growth Fund Q4 2024 Commentary (Seeking Alpha)
Apr-01-25 10:01AM	TransMedics Group (TMDX) Shares Down 60% From Class Period High, Class-Action Suit Pending - Hagens Berman (Newsfile)
05:45AM	TransMedics Group, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky Before April 15, 2025 to Discuss Your Rights - TMDX (PR Newswire)
Mar-31-25 06:51PM	TransMedics Group (TMDX) Shares Down 60% From Class Period High, Class-Action Suit Pending Hagens Berman (GlobeNewswire)
11:36AM	Jim Cramer Finds TransMedics Group, Inc. (TMDX) Interesting but Expensive - Caution Advised! (Insider Monkey)
04:39AM	TransMedics: The Financial Tipping Point That Will Drive Mass Adoption (Seeking Alpha)
Mar-28-25 01:39PM	TransMedics Group (TMDX) Shares Down 60% From Class Period High, Class-Action Suit Pending Hagens Berman (GlobeNewswire)
05:42AM	TransMedics Group Stock: A Millionaire-Maker in the Making? (Motley Fool)
Mar-26-25 02:08PM	TransMedics Group (TMDX) Shares Down 60% From Class Period High, Class-Action Suit Pending Hagens Berman (GlobeNewswire)
Mar-25-25 02:19PM	TransMedics Group (TMDX) Shares Down 60% From Class Period High, Class-Action Suit Pending - Hagens Berman (Newsfile)
08:16AM	TransMedics Group (TMDX) Missed Expectations Due to Seasonality (InsiderMonkey)
Mar-24-25 02:44PM	TransMedics Group (TMDX) Faces Class-Action Suit Over Alleged Fraud and Safety Lapses Hagens Berman (GlobeNewswire)
Mar-22-25 03:31AM	1 Compelling Reason to Buy and Hold TransMedics Group Stock Forever (Motley Fool)
Mar-21-25 01:40PM	TransMedics Group (TMDX) Plunges Amidst Allegations of Fraud, Organ Trafficking Hagens Berman (GlobeNewswire)
05:45AM	TransMedics Group, Inc. Sued for Securities Law Violations - Contact Levi & Korsinsky Before April 15, 2025 to Discuss Your Rights - TMDX (PR Newswire)
Mar-20-25 07:29AM	TransMedics: A Very Bullish Last Few Months Could Change Sentiment (SeekingAlpha)
Mar-19-25 05:15AM	1 Turnaround Growth Stock Down 60% That Could Double, According to Wall Street (Motley Fool)
Mar-18-25 03:48PM	TransMedics Group (TMDX) Faces Class-Action Suit Over Alleged Fraud and Safety Lapses- Hagens Berman (Newsfile)
Mar-17-25 09:31AM	TransMedics Group (TMDX) Slid as Results Fell Short of Expectations (Insider Monkey)
Mar-12-25 11:39AM	TransMedics Group (TMDX) Faces Class-Action Suit Over Alleged Fraud and Safety Lapses- Hagens Berman (Newsfile)
Mar-11-25 05:14AM	Down 62%. Should You Buy TransMedics Stock on the Dip? (Motley Fool)
Mar-06-25 08:51AM	TransMedics Group (TMDX) Faces Class-Action Suit Over Alleged Fraud and Safety Lapses- Hagens Berman (Newsfile)
Mar-04-25 05:45AM	TransMedics Group, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - TMDX (PR Newswire)
Mar-01-25 08:11PM	Kessler Topaz Meltzer & Check, LLP Encourages TransMedics Group, Inc. Investors with Losses to Contact the Firm (PR Newswire)
Feb-28-25 12:47PM	Is TransMedics Group, Inc. (TMDX) the Worst Performing Mid Cap Stock to Buy According to Analysts? (Insider Monkey) +5.82%
05:45AM	TransMedics Group, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky Before April 15, 2025 to Discuss Your Rights - TMDX (PR Newswire)
02:37AM	TransMedics Group Inc (TMDX) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and ... (GuruFocus.com)
Feb-27-25 06:30PM	TransMedics (TMDX) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates (Zacks)
05:30PM	TransMedics (TMDX) Q4 Earnings and Revenues Beat Estimates (Zacks)
04:32PM	TransMedics: Q4 Earnings Snapshot (Associated Press Finance)
04:05PM	TransMedics Reports Fourth Quarter and Full Year 2024 Financial Results (PR Newswire)
08:32AM	TransMedics Group (TMDX) Plunges Amidst Allegations of Fraud, Organ Trafficking - Hagens Berman (Newsfile)
Feb-26-25 07:33AM	TransMedics Group Inc (TMDX) Q4 2024 Earnings Report Preview: What To Expect (GuruFocus.com)
Feb-25-25 05:45AM	TransMedics Group, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky Before April 15, 2025 to Discuss Your Rights - TMDX (PR Newswire) -5.34%
Feb-24-25 09:16AM	Curious about TransMedics (TMDX) Q4 Performance? Explore Wall Street Estimates for Key Metrics (Zacks) +7.19%
Feb-21-25 09:30AM	TransMedics Group (TMDX) Faces Class-Action Suit Over Alleged Fraud and Safety Lapses- Hagens Berman (PR Newswire)
Feb-18-25 04:05PM	TransMedics to Present at Upcoming March Investor Conferences (PR Newswire) +5.87%
12:58PM	Lowey Dannenberg, P.C. is Investigating TransMedics Group, Inc. (NASDAQ:TMDX) for Potential Violations of the Federal Securities Laws (GlobeNewswire)
07:00AM	Scott+Scott Attorneys at Law LLP Reminds Investors That It Has Begun Investigating TransMedics Group, Inc. (TMDX) (Newsfile)
Feb-17-25 06:59AM	Scott+Scott Attorneys at Law LLP Reminds Investors that It is Investigating TransMedics Group, Inc. (TMDX) (Newsfile)
Feb-14-25 11:38AM	Lowey Dannenberg, P.C. is Investigating TransMedics Group, Inc. (NASDAQ:TMDX) for Potential Violations of the Federal Securities Laws (GlobeNewswire)
Feb-13-25 04:05PM	TransMedics to Report Fourth Quarter and Full Year 2024 Financial Results on February 27, 2025 (PR Newswire)
Feb-07-25 01:34PM	Lowey Dannenberg, P.C. is Investigating TransMedics Group, Inc. (NASDAQ:TMDX) for Potential Violations of the Federal Securities Laws (GlobeNewswire)
Feb-04-25 01:31PM	Lowey Dannenberg, P.C. is Investigating TransMedics Group, Inc. (NASDAQ:TMDX) for Potential Violations of the Federal Securities Laws (GlobeNewswire)

TransMedics Group, Inc. operates as a commercial stage medical technology company. The firm engages in the development and commercialization of organ care system platform. It focuses on the preservation of human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation. The company was founded by Waleed H. Hassanein in August 1998 and is headquartered in Andover, MA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Ranganath Anil P.	See remarks	Jun 09 '25	Sale	139.80	686	95,903	13,955	Jun 10 04:44 PM
Basile Edward M	Director	May 27 '25	Option Exercise	0.70	5,000	3,500	7,866	May 29 04:30 PM
Basile Edward M	Director	May 27 '25	Sale	126.45	5,000	632,250	2,866	May 29 04:30 PM
EDWARD BASILE	Director	May 27 '25	Proposed Sale	126.45	5,000	632,250		May 27 04:18 PM
Weill David	Director	May 23 '25	Sale	123.88	732	90,680	12,134	May 23 06:41 PM
DAVID WEILL	Director	May 23 '25	Proposed Sale	123.88	732	90,683		May 23 05:26 PM
Basile Edward M	Director	May 09 '25	Option Exercise	0.70	6,000	4,200	6,732	May 13 05:43 PM
Basile Edward M	Director	May 09 '25	Sale	115.63	6,000	693,780	732	May 13 05:43 PM
EDWARD BASILE	Director	May 09 '25	Proposed Sale	115.63	6,000	693,780		May 09 04:02 PM
Khayal Tamer I	Chief Commercial Officer	Mar 03 '25	Sale	76.43	2,407	183,967	36,042	Mar 05 04:30 PM
Gordon Stephen	Officer	Mar 04 '25	Proposed Sale	65.61	5,942	389,855		Mar 04 11:33 AM
Khayal Tamer I	Chief Commercial Officer	Jan 07 '25	Option Exercise	13.28	1,083	14,382	21,926	Jan 10 04:29 PM
Khayal Tamer I	Chief Commercial Officer	Jan 07 '25	Sale	80.05	1,083	86,694	20,843	Jan 10 04:29 PM
Khayal Tamer I	Chief Commercial Officer	Dec 02 '24	Option Exercise	13.28	1,084	14,396	21,927	Dec 04 06:00 PM
Khayal Tamer I	Chief Commercial Officer	Dec 02 '24	Sale	86.40	1,084	93,658	20,843	Dec 04 06:00 PM
Khayal Tamer I	Chief Commercial Officer	Nov 11 '24	Option Exercise	38.46	1,458	56,075	22,301	Nov 13 04:30 PM
Khayal Tamer I	Chief Commercial Officer	Nov 11 '24	Sale	90.04	1,458	131,278	20,843	Nov 13 04:30 PM
Basile Edward M	Director	Nov 05 '24	Option Exercise	28.12	6,750	189,810	7,482	Nov 07 04:30 PM
Basile Edward M	Director	Nov 05 '24	Sale	83.55	6,750	563,994	732	Nov 07 04:30 PM
Khayal Tamer I	Chief Commercial Officer	Nov 01 '24	Option Exercise	13.28	1,083	14,382	21,926	Nov 05 04:30 PM
Khayal Tamer I	Chief Commercial Officer	Nov 01 '24	Sale	82.64	1,083	89,499	20,843	Nov 05 04:30 PM
EDWARD BASILE	Director	Nov 05 '24	Proposed Sale	83.56	6,750	564,008		Nov 05 04:10 PM
Tamer Khayal	Officer	Nov 01 '24	Proposed Sale	81.97	7,625	625,021		Nov 01 04:09 PM
Hassanein Waleed H	President & CEO	Oct 15 '24	Option Exercise	13.28	8,625	114,540	70,268	Oct 17 04:30 PM
Hassanein Waleed H	President & CEO	Oct 15 '24	Sale	132.71	8,625	1,144,648	61,643	Oct 17 04:30 PM
Khayal Tamer I	Chief Commercial Officer	Oct 01 '24	Option Exercise	33.14	2,958	98,021	23,801	Oct 03 04:30 PM
Khayal Tamer I	Chief Commercial Officer	Oct 01 '24	Sale	148.24	2,958	438,491	20,843	Oct 03 04:30 PM
Hassanein Waleed H	President & CEO	Sep 16 '24	Option Exercise	13.28	8,625	114,540	70,268	Sep 17 07:31 PM
Hassanein Waleed H	President & CEO	Sep 16 '24	Sale	153.42	8,625	1,323,210	61,643	Sep 17 07:31 PM
Khayal Tamer I	Chief Commercial Officer	Sep 03 '24	Option Exercise	33.13	2,960	98,072	23,803	Sep 05 04:30 PM
Khayal Tamer I	Chief Commercial Officer	Sep 03 '24	Sale	159.60	2,960	472,404	20,843	Sep 05 04:30 PM
Corcoran Nicholas	See Remarks	Aug 27 '24	Option Exercise	69.83	10,000	698,318	31,105	Aug 29 04:30 PM
Corcoran Nicholas	See Remarks	Aug 27 '24	Sale	176.02	10,000	1,760,200	21,105	Aug 29 04:30 PM
Corcoran Nicholas	Officer	Aug 27 '24	Proposed Sale	176.02	10,000	1,760,158		Aug 27 05:32 PM
Hassanein Waleed H	President & CEO	Aug 22 '24	Option Exercise	16.14	25,000	403,500	86,643	Aug 23 04:30 PM
Hassanein Waleed H	President & CEO	Aug 21 '24	Option Exercise	16.00	20,000	320,000	81,643	Aug 23 04:30 PM
Hassanein Waleed H	President & CEO	Aug 22 '24	Sale	175.00	25,000	4,375,000	61,643	Aug 23 04:30 PM
Hassanein Waleed H	President & CEO	Aug 21 '24	Sale	171.03	20,000	3,420,600	61,643	Aug 23 04:30 PM
Hassanein Waleed H	Officer	Aug 21 '24	Proposed Sale	173.22	45,000	7,795,000		Aug 21 04:34 PM
Hassanein Waleed H	President & CEO	Aug 15 '24	Option Exercise	13.28	8,625	114,540	70,268	Aug 19 04:30 PM
Hassanein Waleed H	President & CEO	Aug 15 '24	Sale	169.73	8,625	1,463,919	61,643	Aug 19 04:30 PM
Waleed H. Hassanein	Director	Aug 15 '24	Proposed Sale	163.08	25,875	4,219,695		Aug 15 05:11 PM
Ranganath Anil P.	See remarks	Aug 07 '24	Option Exercise	93.88	4,289	402,651	13,182	Aug 09 04:30 PM
Ranganath Anil P.	See remarks	Aug 07 '24	Sale	152.20	4,289	652,786	8,893	Aug 09 04:30 PM
TOBIN JAMES R	Director	Aug 08 '24	Sale	159.33	20,000	3,186,536	173,146	Aug 09 04:30 PM
Basile Edward M	Director	Aug 06 '24	Option Exercise	28.12	6,750	189,810	7,482	Aug 08 04:30 PM
Basile Edward M	Director	Aug 06 '24	Sale	149.96	6,750	1,012,230	732	Aug 08 04:30 PM
James R. Tobin	Director	Aug 08 '24	Proposed Sale	145.85	20,000	2,917,000		Aug 08 04:03 PM
Ranganath Anil P.	Officer	Aug 07 '24	Proposed Sale	152.20	4,289	652,786		Aug 07 04:25 PM
EDWARD BASILE	Director	Aug 06 '24	Proposed Sale	149.96	6,750	1,012,225		Aug 06 04:12 PM
Khayal Tamer I	Chief Commercial Officer	Aug 01 '24	Option Exercise	33.14	2,958	98,021	23,801	Aug 05 06:08 PM
Khayal Tamer I	Chief Commercial Officer	Aug 01 '24	Sale	156.77	2,958	463,727	20,843	Aug 05 06:08 PM
Tamer Khayal	Officer	Aug 01 '24	Proposed Sale	163.81	8,876	1,453,976		Aug 01 04:08 PM
Hassanein Waleed H	President & CEO	Jul 15 '24	Option Exercise	13.28	8,625	114,540	70,268	Jul 17 04:30 PM
Hassanein Waleed H	President & CEO	Jul 15 '24	Sale	145.17	8,625	1,252,051	61,643	Jul 17 04:30 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

TMDX

Transmedics Group Inc

Upgrade your FINVIZ experience